THRX-956485

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTHRX-956485
Drug Alias Nameserotonin transport reuptake inhibitor (Theravance)THRX-956485
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitorsSerotonin reuptake inhibitorsCoagulation factor inhibitors
TargetsCoagulation factorSerotonin transporter
Therapy Area/IndicationsThrombosisHypertension, PulmonaryOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnoviva Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnoviva Inc
Active IndicationsN/A
Inactive IndicationsThrombosisHypertension, PulmonaryOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A